ARCHIVES

FTC Report Disagrees With Key Provision Of Biologics Bill Backed By Companies

This article is from The Cancer Letter archive.

Vol. 35 No. 23 | June 12, 2009

Download PDF Visit The Full Archive

Related Articles

New Drug Combination Shrinks Kidney Cancers

June 30, 2006

“Landmark” Fundings Reported n Interferon Genes, Ovarian And Pancreas Markers

April 17, 1981

Comment period for biospecimen network proposal extended.

January 16, 2004

FDA To Once Again Review ESA Label To Reflect Results Of Negative Studies.

December 7, 2007

In Brief: Alfred Ketcham Is New SSO President; Meyskens Receives NCI Year 2000 Award; Colman Honored

August 10, 1990

Revlimid Plus Steroid Effective In Clinical Trial

November 30, 2007